GOSS 8-K 2026-09-28
Gossamer Bio, Inc. (GOSS) 8-K dated 2026-09-28 — accession 0001728117-26-000106.
Gossamer Bio, Inc. (GOSS) is a biotechnology company listed on US.
Gossamer Bio, Inc. filed a 8-K on 2026-09-28. Accession 0001728117-26-000106.
This 8-K covers: Other events (Item 8.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported GOSS revenue for 2025-12-31 was $48.5M. Net income was -$170.4M. Revenue was down 57.7% from 2024-12-31 to 2025-12-31. GOSS currently screens at market cap $47.0M.
Not investment advice. The GOSS SEC hub lists recent forms. The stock page is the research view.